First Choice Healthcare Solutions, Inc.

OTCPK:FCHS Stock Report

Market Cap: US$171.4k

First Choice Healthcare Solutions Valuation

Is FCHS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FCHS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate FCHS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate FCHS's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FCHS?

Key metric: As FCHS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for FCHS. This is calculated by dividing FCHS's market cap by their current revenue.
What is FCHS's PS Ratio?
PS Ratio7.3x
SalesUS$23.63k
Market CapUS$171.38k

Price to Sales Ratio vs Peers

How does FCHS's PS Ratio compare to its peers?

The above table shows the PS ratio for FCHS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.08x
CLRD Clearday
0.02xn/aUS$149.4k
MEDV.F Medivolve
0.2xn/aUS$148.6k
CMAX.Q CareMax
0.0006x26.0%US$457.8k
NVOS Novo Integrated Sciences
0.07xn/aUS$952.7k
FCHS First Choice Healthcare Solutions
7.3xn/aUS$171.4k

Price-To-Sales vs Peers: FCHS is expensive based on its Price-To-Sales Ratio (7.3x) compared to the peer average (0.1x).

Price to Sales Ratio vs Industry

How does FCHS's PS Ratio compare vs other companies in the US Healthcare Industry?

30 CompaniesPrice / SalesEstimated GrowthMarket Cap
MCK McKesson
0.2x8.1%US$77.69b
CVS CVS Health
0.2x4.6%US$73.05b
COR Cencora
0.2x6.5%US$48.00b
CAH Cardinal Health
0.1x5.5%US$30.31b
FCHS 7.3xIndustry Avg. 1.1xNo. of Companies30PS012345+
30 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: FCHS is expensive based on its Price-To-Sales Ratio (7.3x) compared to the US Healthcare industry average (1.1x).

Price to Sales Ratio vs Fair Ratio

What is FCHS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FCHS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio7.3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate FCHS's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y